Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382122 · ClinicalTrials.gov registry record
Prevalence of Ocular Surface Disease in Glaucoma Patients
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 101
- Enrollment target
NCT00382122: Completed study, sponsored by Alcon Research.
NCT00382122 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00382122 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-02 |
What the finished NCT00382122 record still lists
NCT00382122 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00382122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00382122 about?
NCT00382122 is a clinical study titled "Prevalence of Ocular Surface Disease in Glaucoma Patients". Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular...
What is the current status of trial NCT00382122?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2006-09. Estimated completion is 2007-02.
Who is sponsoring clinical trial NCT00382122?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia